BackVeradermicsorporated Overview

Veradermicsorporated Current Cash

Veradermicsorporated's current cash is $320M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$319.33M

Peer trimmed avg / median

Loading

Veradermicsorporated Current Cash History

Loading

Veradermicsorporated vs. peers: Current Cash Comparison

Loading

Veradermicsorporated Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Veradermicsorporated (MANE) FAQ

Veradermicsorporated's current cash stands at $320M as of June 2026. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Open the history chart to see whether Veradermicsorporated's current cash is expanding or contracting. Sustained growth in current cash can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Veradermicsorporated's current cash evolved across reporting periods, while the comparison chart places MANE next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, current cash is commonly used to spot outliers. Veradermicsorporated's reading of $320M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.